Akero Therapeutics shares owned by Citadel Advisors
Quarter-by-quarter ownership of Akero Therapeutics (AKRO) shares owned by Citadel Advisors
from 13F filings
Historical chart of Citadel Advisors investment in Akero Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Akero Therapeutics held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Akero Therapeutics by Citadel Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $6.3M | 221k | 28.69 |
| 2024-06-30 | $12M | 500k | 23.46 |
| 2024-03-31 | $14M | 567k | 25.26 |
| 2023-12-31 | $15M | 638k | 23.35 |
| 2023-09-30 | $20M | 389k | 50.58 |
| 2023-06-30 | $18M | 376k | 46.69 |
| 2023-03-31 | $36M | 933k | 38.26 |
| 2022-12-31 | $24M | 433k | 54.80 |
| 2022-06-30 | $932k | 99k | 9.45 |
| 2022-03-31 | $1.2M | 88k | 14.19 |
| 2021-12-31 | $580k | 27k | 21.15 |
| 2021-09-30 | $1.1M | 47k | 22.34 |
| 2021-06-30 | $2.0M | 82k | 24.79 |
| 2021-03-31 | $5.9M | 203k | 29.03 |
| 2020-12-31 | $5.8M | 225k | 25.77 |
| 2020-09-30 | $1.3M | 41k | 30.86 |
| 2020-06-30 | $1.6M | 66k | 24.92 |
| 2020-03-31 | $297k | 14k | 21.21 |
| 2019-12-31 | $459k | 21k | 22.17 |
| 2019-09-30 | $518k | 23k | 22.30 |